Category Archives: Embryonic Stem Cells

Stem Cell Therapy Market Size, Analytical Overview, Key Players, Growth Factors, Demand, Trends And Forecast to 2027 – The Daily Chronicle

Allosource

Request a Discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=33553

Additionally, the report is furnished by the advanced analytical data from SWOT analysis, Porters Five Forces Analysis, Feasibility Analysis, and Investment Return Analysis. The report also provides a detailed analysis of the mergers, consolidations, acquisitions, partnerships, and government deals. Along with this, an in-depth analysis of current and emerging trends, opportunities, threats, limitations, entry-level barriers, restraints and drivers, and estimated market growth throughout the forecast period are offered in the report.

Market Breakdown:

The market breakdown provides market segmentation data based on the availability of the data and information. The market is segmented on the basis of types and applications.

1.Stem Cell Therapy Market, By Cell Source:

Adipose Tissue-Derived Mesenchymal Stem Cells Bone Marrow-Derived Mesenchymal Stem Cells Cord Blood/Embryonic Stem Cells Other Cell Sources

2.Stem Cell Therapy Market, By Therapeutic Application:

Musculoskeletal Disorders Wounds and Injuries Cardiovascular Diseases Surgeries Gastrointestinal Diseases Other Applications

3.Stem Cell Therapy Market, By Type:

Allogeneic Stem Cell Therapy Market, By Application Musculoskeletal Disorders Wounds and Injuries Surgeries Acute Graft-Versus-Host Disease (AGVHD) Other Applications Autologous Stem Cell Therapy Market, By Application Cardiovascular Diseases Wounds and Injuries Gastrointestinal Diseases Other Applications

Request customization of the report @https://reportsglobe.com/need-customization/?rid=33553

The report provides additional analysis about the key geographical segments of the Stem Cell Therapy Market and provides analysis about their current and previous share. Current and emerging trends, challenges, opportunities, and other influencing factors are presented in the report.

Regional analysis includes an in-depth study of the key geographical regions to gain a better understanding of the market and provide an accurate analysis. The regional analysis coversNorth America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa.

Objectives of the Report:

To learn more about the report, visit @ https://reportsglobe.com/product/global-stem-cell-therapy-market/

Thank you for reading our report. To learn more about report details or for customization information, please contact us. Our team will ensure that the report is customized according to your requirements.

How Reports Globe is different than other Market Research Providers

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email:[emailprotected]

Web:reportsglobe.com

Read the rest here:
Stem Cell Therapy Market Size, Analytical Overview, Key Players, Growth Factors, Demand, Trends And Forecast to 2027 – The Daily Chronicle

Stem Cell Manufacturing Market 2020 Global Industry Analysis, Size, Growth, Trends, Share, COVID-19 Impact Analysis, and Forecast 2027| Merck Group,…

Data Bridge Market Research recently introducedGlobal Stem Cell Manufacturing Market Size, Industry Share, Growth, Industry Trends and Forecast To 2027study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2027. Global Stem Cell Manufacturing Market explores effective study on varied sections of Industry like opportunities, size, growth, technology, demand and trend of high leading players. It also provides market key statistics on the status of manufacturers, a valuable source of guidance, direction for companies and individuals interested in the industry. This report showcases the latest trends in the global and regional markets on all critical parameters which include technology, supplies, capacity, production, profit, price, and competition. The growth of the Stem Cell Manufacturing market was mainly driven by the increasing R&D spending across the world, however latest COVID scenario and economic slowdown have changed complete market dynamics.

Stem cell manufacturing is forecasted to grow at CAGR of 6.42% to an anticipated value of USD 18.59 billion by 2027 with factors like rising awareness towards diseases like cancer, degenerative disorders and hematopoietic disorders is driving the growth of the market in the forecast period of 2020-2027.

Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this[emailprotected]https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-stem-cell-manufacturing-market&AB

Stem cell manufacturing has shown an exceptional penetration in North America due to increasing research in stem cell. Increasing research and development activities in biotechnology and pharmaceutical sector is creating opportunity for the stem cell manufacturing market.

The Global Stem Cell Manufacturing Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Stem Cell Manufacturing Market Share analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.

Global Stem Cell Manufacturing Market Segematation By Product (Stem Cell Line, Instruments, Culture Media, Consumables), Application (Research Applications, Clinical Applications, Cell and Tissue Banking), End Users (Hospitals and Surgical Centers, Pharmaceutical and Biotechnology Companies, Clinics, Community Healthcare, Others)

List of TOP KEY PLAYERS in Stem Cell Manufacturing Market Report are

Thermo Fisher Scientific Merck KGaA BD JCR Pharmaceuticals Co., Ltd Organogenesis Inc Osiris Vericel Corporation AbbVie Inc AM-Pharma B.V ANTEROGEN.CO.,LTD Astellas Pharma Inc Bristol-Myers Squibb Company FUJIFILM Cellular Dynamics, Inc RHEACELL GmbH & Co. KG Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Ltd ViaCyte,Inc VistaGen Therapeutics Inc GlaxoSmithKline plc ..

Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart)@https://www.databridgemarketresearch.com/toc/?dbmr=global-stem-cell-manufacturing-market&AB

The report can help to understand the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Stem Cell Manufacturing industry. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. For each manufacturer covered, this report analyzes their Stem Cell Manufacturing manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The Global Stem Cell Manufacturing Market Trends, development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.

Global Stem Cell Manufacturing Market Scope and Market Size

Stem cell manufacturing market is segmented on the basis of product, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based on product, the stem cell manufacturing market is segmented into stem cell lines, instruments, culture media and consumables. Stem cell lines are further segmented into induced pluripotent stem cells, embryonic stem cells, multipotent adult progenitor stem cells, mesenchymal stem cells, hematopoietic stem cells, neural stem cells. Instrument is further segmented into bioreactors and incubators, cell sorters and other instruments.

On the basis of application, the stem cell manufacturing market is segmented into research applications, clinical applications and cell and tissue banking. Research applications are further segmented into drug discovery and development and life science research. Clinical applications are further segmented into allogenic stem cell and autologous stem cell therapy.

On the basis of end users, the stem cell manufacturing market is segmented into hospitals and surgical centers, pharmaceutical and biotechnology companies, research institutes and academic institutes, community healthcare, cell banks and tissue banks and others.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Stem cell manufacturing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for stem cell manufacturing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the stem cell manufacturing market. The data is available for historic period 2010 to 2018.

The Global Stem Cell Manufacturing Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of stem cell manufacturing market for global, Europe, North America, Asia Pacific and South America.

Key Insights in the report:

Historical and current market size and projection up to 2025

Market trends impacting the growth of the global taste modulators market

Analyze and forecast the taste modulators market on the basis of, application and type.

Trends of key regional and country-level markets for processes, derivative, and application Company profiling of key players which includes business operations, product and services, geographic presence, recent developments and key financial analysis

For More Information or Query or Customization Before Buying, Visit @https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-stem-cell-manufacturing-market&AB

Opportunities in the market

To describe and forecast the market, in terms of value, for various segments, by region North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW)

The key findings and recommendations highlight crucial progressive industry trends in the Stem Cell manufacturing Market, thereby allowing players to develop effective long term strategies

To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across Europe.

To get a comprehensive overview of the Stem Cell manufacturing market.

With tables and figures helping analyses worldwide Global Stem Cell Manufacturing Market Forecast this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. There are 15 Chapters to display the Stem Cell Manufacturing market.

Chapter 1, About Executive Summary to describe Definition, Specifications and Classification of Stem Cell Manufacturing market, By Product Type, by application, by end users and regions.

Chapter 2, objective of the study.

Chapter 3, to display Research methodology and techniques.

Chapter 4 and 5, to show the Stem Cell Manufacturing Market Analysis, segmentation analysis, characteristics;

Chapter 6 and 7, to show Five forces (bargaining Power of buyers/suppliers), Threats to new entrants and market condition;

Chapter 8 and 9, to show analysis by regional segmentation[North America, Europe, Asia-Pacific etc ], comparison, leading countries and opportunities; Regional Marketing Type Analysis, Supply Chain Analysis

Chapter 10, to identify major decision framework accumulated through Industry experts and strategic decision makers;

Chapter 11 and 12, Stem Cell Manufacturing Market Trend Analysis, Drivers, Challenges by consumer behavior, Marketing Channels

Chapter 13 and 14, about vendor landscape (classification and Market Ranking)

Chapter 15, deals with Stem Cell Manufacturing Market sales channel, distributors, Research Findings and Conclusion, appendix and data source.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Oceania [Australia and New Zealand]

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

Our Upcoming Event: Rare Disease and Orphan Drugs |Digital Conference

Go here to see the original:
Stem Cell Manufacturing Market 2020 Global Industry Analysis, Size, Growth, Trends, Share, COVID-19 Impact Analysis, and Forecast 2027| Merck Group,…

The Fascinating Story of Q Stock BioRestorative Therapies Inc (OTCMKTS: BRTXQ) – MicroCap Daily

Post Views: 1,854

BioRestorative Therapies Inc (OTCMKTS: BRTXQ) is easily among the most exciting stocks in small caps quickly attracting legions of penny stocks speculators and emerging as a volume leader in small caps. Q stocks are notoriously volatile and have been some of the biggest runners in small caps history.

BioRestorative filed for bankruptcy protection in March but has partnered on a new bankruptcy reorganization plan with one of its creditors Auctus Capital in which the Company would emerge from bankruptcy with the commons intact, ready to begin their phase 2 trials and get BioRestorative back on a national stock exchange. On September 10th, a hearing was held for confirmation of the bankruptcy reorganization plan submitted jointly by the company and Auctus Capital Partners. Based on notes in Pacer, the plan has been confirmed, judges order pending, but expected soon, likely the week of September 14, 2020.

BioRestorative Therapies Inc (OTCMKTS: BRTXQ) operating out of Melvile, New York is a life sciences company focused on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The Company was founded by scientists and researchers committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions. BioRestorative Therapies advances in stem cell biology and delivery protocols harbor great promise in conditioning our bodies own regenerative potential to treat major diseases more effectively than current interventions. Today, BioRestorative is actively developing programs that aim to dramatically increase quality of care for both chronic back pain caused by disc degeneration, as well as metabolic disorders including obesity and diabetes. BioRestorative Therapies lead cell therapy candidate, BRTX-100 is a novel product to treat damaged, degenerating discs, and is anticipated to be safer, cheaper, and more effective upon a single treatment. Specifically, BRTX-100 is an autologous stem cell product that uses your own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. The Company has received authorization from the FDA to commence a Phase 2 clinical trial using BRTX-100 to treat persistent lower back pain due to painful degenerative discs.

The Company is also developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells, or BADSC, to generate brown adipose tissue, or BAT. BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in animals may be responsible for additional caloric burning, as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.

To Find out the inside Scoop on BioRestorative Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

BioRestorative owns a valuable intelectual property portfolio including unique international Stem Cell patents as well as 8 patents issued, in the United States and other countries, for the Companys brown fat technology related to BioRestoratives metabolic program (ThermoStem Program).

On March 20 BioRestorative filed a voluntary petition commencing a case under chapter 11 of title 11 of the U.S. Code in the United States Bankruptcy Court for the Eastern District of New York. The Companys chapter 11 case is being administered under the caption, In re: BioRestorative Therapies, Inc., Case No. 8-20-71757.

Initially intellectual property lawyer John Desmarais entered into a stalking horse agreement to buy the company. He would pay $500,000 to acquire the company, along with their assets (including the intellectual property). The deal with Desmarais fell apart in July when Auctus Capital partnered with the Company on a new bankruptcy reorganization plan in which the Company would emerge from bankruptcy with the commons intact, ready to begin their phase 2 trials and get BioRestorative back on a national stock exchange. On September 10th, a hearing was held for confirmation of the bankruptcy reorganization plan submitted jointly by the company and Auctus Capital Partners. Based on notes in Pacer, the plan has been confirmed, judges order pending, but expected soon, likely the week of September 14, 2020. Further detail will be added upon review of the judges order, but the plan and disclosure statement are available to Pacer or Pacermonitor subscribers.

We have a Monster Pick Coming. Subscribe Right Now!

Currently running northbound in a hurry BioRestorative is an exciting story developing in small caps; BioRestorative filed for bankruptcy protection in March but has partnered on a new bankruptcy reorganization plan with one of its creditors Auctus Capital in which the Company would emerge from bankruptcy with the commons intact, ready to begin their phase 2 trials and get BioRestorative back on a national stock exchange. On September 10th, a hearing was held for confirmation of the bankruptcy reorganization plan submitted jointly by the company and Auctus Capital Partners. Based on notes in Pacer, the plan has been confirmed, judges order pending, but expected soon, likely the week of September 14, 2020. BioRestorative owns a valuable intelectual property portfolio including unique international Stem Cell patents as well as 8 patents issued, in the United States and other countries, for the Companys brown fat technology related to BioRestoratives metabolic program (ThermoStem Program). We will be updating on BioRestorative when more details emerge so make sure you are subscribed to Microcapdaily so you know whats going on with BioRestorative.

Disclosure: we hold no position in BRTXQ either long or short and we have not been compensated for this article.

Share.

Here is the original post:
The Fascinating Story of Q Stock BioRestorative Therapies Inc (OTCMKTS: BRTXQ) – MicroCap Daily

Global Stem Cell Therapy Market 2020 Research on Import-Export Details, Business Standards and Forecast to 2025 – Scientect

Stem Cell Therapy Market Research Report Cover Covid-19 Outbreak:

Brand Essence Market Research has developed a concise study on the Stem Cell Therapy market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline.

Download Premium Sample of the Report: https://brandessenceresearch.biz/Request/Sample?ResearchPostId=72717&RequestType=Sample

TheMajorPlayersCovered in this Report:Gilead,Novartis,Organogenesis,Vericel & More.

Product Type: Adult Stem Cells,Human Embryonic Stem Cells (hESC),Induced Pluripotent Stem Cells,Very Small Embryonic Like Stem Cells

Application: Regenerative Medicine,Drug Discovery and Development

Results of the recent scientific undertakings towards the development of new Stem Cell Therapy products have been studied. Nevertheless, the factors affecting the leading industry players to adopt synthetic sourcing of the market products have also been studied in this statistical surveying report. The conclusions provided in this report are of great value for the leading industry players. Every organization partaking in the global production of the Stem Cell Therapy market products have been mentioned in this report, in order to study the insights on cost-effective manufacturing methods, competitive landscape, and new avenues for applications.

Global Stem Cell TherapyMarket: Regional Segmentation For further clarification, analysts have also segmented the market on the basis of geography. This type of segmentation allows the readers to understand the volatile political scenario in varying geographies and their impact on the global Stem Cell Therapymarket. On the basis of geography, the global market for Stem Cell Therapyhas been segmented into:

North America(United States, Canada, and Mexico) Europe(Germany, France, UK, Russia, and Italy) Asia-Pacific(China, Japan, Korea, India, and Southeast Asia) South America(Brazil, Argentina, Colombia, etc.) Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Request Cutomization @https://brandessenceresearch.biz/Request/Sample?ResearchPostId=72717&RequestType=Methodology

Report Methodology:

The information enclosed in this report is based upon both primary and secondary research methodologies.

Primary research methodology includes the interaction with service providers, suppliers, and industry professionals. Secondary research methodology includes a meticulous search of pertinent publications like company annual reports, financial reports, and exclusive databases.

Table of Content:

Market Overview: The report begins with this section where product overview and highlights of product and application segments of the Global Stem Cell Therapy Market are provided. Highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

Competition by Company: Here, the competition in the Worldwide Global Stem Cell Therapy Market is analyzed, By price, revenue, sales, and market share by company, market rate, competitive situations Landscape, and latest trends, merger, expansion, acquisition, and market shares of top companies.

Company Profiles and Sales Data: As the name suggests, this section gives the sales data of key players of the Global Stem Cell Therapy Market as well as some useful information on their business. It talks about the gross margin, price, revenue, products, and their specifications, type, applications, competitors, manufacturing base, and the main business of key players operating in the Global Stem Cell Therapy Market.

Market Status and Outlook by Region: In this section, the report discusses about gross margin, sales, revenue, production, market share, CAGR, and market size by region. Here, the Global Stem Cell Therapy Market is deeply analyzed on the basis of regions and countries such as North America, Europe, China, India, Japan, and the MEA.

Application or End User: This section of the research study shows how different end-user/application segments contribute to the Global Stem Cell Therapy Market.

Market Forecast: Here, the report offers a complete forecast of the Global Stem Cell Therapy Market by product, application, and region. It also offers global sales and revenue forecast for all years of the forecast period.

Research Findings and Conclusion: This is one of the last sections of the report where the findings of the analysts and the conclusion of the research study are provided.

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Top Trending Reports:

https://www.marketwatch.com/press-release/document-camera-market-2020-industry-research-share-trend-global-industry-size-price-future-analysis-regional-outlook-to-2025-2020-09-07?tesla=y

https://www.marketwatch.com/press-release/global-3d-machine-vision-market-2020-industry-analysis-size-share-trends-segmentation-and-forecast-to-2025-2020-09-07?tesla=y

https://www.marketwatch.com/press-release/weight-loss-and-weight-management-diet-market-size-growth-opportunity-and-forecast-to-2025-2020-09-07?tesla=y

https://www.marketwatch.com/press-release/weight-loss-and-weight-management-diet-market-size-growth-opportunity-and-forecast-to-2025-2020-09-07?tesla=y

https://www.marketwatch.com/press-release/at-cagr-45-nematicides-market-demand-types-high-growth-business-opportunities-applications-market-share-and-industry-size-till-2025-2020-09-11?tesla=y

Read the rest here:
Global Stem Cell Therapy Market 2020 Research on Import-Export Details, Business Standards and Forecast to 2025 – Scientect

Study Focuses On New Discovery In Regenerative Medicine | newkerala.com Health News – New Kerala

ANI | 1 day ago

iPSCs opened up the potential for personalised cell therapies and new opportunities for regenerative medicine, safe drug testing, and toxicity assessments, however little was known about exactly how they were made.

An international team led by ARC Future Fellow Professor Jose Polo from Monash University’s Biomedicine Discovery Institute and the Australian Research Medicine Institute, together with Assistant Professor Owen Rackham from Duke-NUS in Singapore, examined the molecular changes the adult skin cells went through to become iPSCs. It was during the study of this process that they discovered a new way to create induced trophoblast stem cells (iTSCs) that can be used to make placenta cells.

This exciting discovery, also involving the expertise of three first authors, Dr Xiaodong Liu, Dr John Ouyang and Dr Fernando Rossello, will enable further research into new treatments for placenta complications and the measurement of drug toxicity to placenta cells, which has implications during pregnancy.

“This is really important because iPSCs cannot give rise to placenta, thus all the advances in disease modelling and cell therapy that iPSCs have brought about did not translate to the placenta,” Professor Polo said.

“When I started my PhD five years ago our goal was to understand the nuts and bolts of how iPSCs are made, however along the way we also discovered how to make iTSCs,” said Dr Liu.

“This discovery will provide the capacity to model human placenta in vitro and enable a pathway to future cell therapies,” commented Dr Ouyang.

“This study demonstrates how by successfully combining both cutting edge experimental and computational tools, basic science leads to unexpected discoveries that can be transformative,” Professor Rackham said.

Professors Polo and Rackham said many other groups from Australian and international universities contributed to the study over the years, making it a truly international endeavour.

Share

Link

Share

Class

Send

Send

You May Also Like This!

Originally posted here:
Study Focuses On New Discovery In Regenerative Medicine | newkerala.com Health News – New Kerala

Transcriptional Regulation in Embryonic Stem Cells …

Abstract

Transcriptional regulation is a pivotal process that confers cellular identity and modulates the biological activities within a cell. In embryonic stem cells (ESCs), the intricate interplay between transcription factors and their targets on the genomic template serves as building blocks for the transcriptional network that governs self-renewal and pluripotency. At the heart of this complex network is the transcription factor trio, Oct4, Sox2 and Nanog, which constitute the ESC transcriptional core. Regulatory mechanisms such as autoregulatory and feedforward loops support the ESC transcriptional framework and serve as homeostatic control for ESC maintenance. Large-scale studies such as loss of function RNAi screens and transcriptome analysis have led to the identification of more players that support pluripotency. In addition, genome-wide localization studies of transcription factors have further unraveled the interconnectivity within the ESC transcriptional circuitry. Transcription factors also work in concert with epigenetic factors and together, this crosstalk between transcriptional and epigenetic regulation maintains the homeostasis of ESC. This chapter provides an overview of the significance of transcriptional regulation in ESC and traces the recent advances made in dissecting the ESC transcriptional regulatory network.

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content,

to check access.

Unable to display preview.Download preview PDF.

1.

Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860921.

2.

Johnson KM, Mitsouras K, Carey M. Eukaryotic transcription: the core of eukaryotic gene activation. Curr Biol 2001; 11:R5103.

3.

Levine M, Tjian R. Transcription regulation and animal diversity. Nature 2003; 424:14751.

4.

Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001; 19:2718.

5.

Nichols J, Zevnik B, Anastassiadis K et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998; 95:37991.

6.

Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24:3726.

7.

Niwa H, Toyooka Y, Shimosato D et al. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 2005; 123:91729.

8.

Avilion AA, Nicolis SK, Pevny LH et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003; 17:12640.

9.

Masui S, Nakatake Y, Toyooka Y et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 2007; 9:62535.

10.

Kopp JL, Ormsbee BD, Desler M et al. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 2008; 26:903911.

11.

Rodda DJ, Chew JL, Lim LH et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005; 280:247317.

12.

Kuroda T, Tada M, Kubota H et al. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 2005; 25:247585.

13.

Ambrosetti DC, Scholer HR, Dailey L et al. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J Biol Chem 2000; 275:2338797.

14.

Ambrosetti DC, Basilico C, Dailey L. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol 1997; 17:63219.

15.

Botquin V, Hess H, Fuhrmann G et al. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev 1998; 12:207390.

16.

Nishimoto M, Fukushima A, Okuda A et al. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol Cell Biol 1999; 19:545365.

17.

Yuan H, Corbi N, Basilico C et al. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 1995; 9:263545.

18.

Chew JL, Loh YH, Zhang W et al. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/ Sox2 complex in embryonic stem cells. Mol Cell Biol 2005; 25:603146.

19.

Okumura-Nakanishi S, Saito M, Niwa H et al. Oct-3/4 and Sox2 Regulate Oct-3/4 Gene in Embryonic Stem Cells. J Biol Chem 2005; 280:53075317.

20.

Remenyi A, Lins K, Nissen LJ et al. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev 2003; 17:204859.

21.

Williams DC, Jr., Cai M, Clore GM. Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42-kDa Oct1.Sox2.Hoxb1-DNA ternary transcription factor complex. J Biol Chem 2004; 279:144957.

22.

Maruyama M, Ichisaka T, Nakagawa M et al. Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells. J Biol Chem 2005; 280:2437124379.

23.

Mullin N P, Yates A, Rowe AJ et al. The pluripotency rheostat Nanog functions as a dimer. Biochem J 2008; 227231.

24.

Wang W, Lin C, Lu D et al. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci USA 2008; 105:92905.

25.

Chambers I, Colby D, Robertson M et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003; 113:64355.

26.

Mitsui K, Tokuzawa Y, Itoh H et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113:63142.

27.

Ivanova N, Dobrin R, Lu R et al. Dissecting self-renewal in stem cells with RNA interference. Nature 2006; 442:5338.

28.

Loh YH, Wu Q, Chew JL et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006; 38:43140.

29.

Chambers I, Silva J, Colby D et al. Nanog safeguards pluripotency and mediates germline development. Nature 2007; 450:12304.

30.

Niwa H, Ogawa K, Shimosato D et al. A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 2009; 460:11822.

31.

Kalmar T, Lim C, Hayward P et al. Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. PLoS Biol 2009; 7:e1000149.

32.

Carter MG, Stagg CA, Falco G et al. An in situ hybridization-based screen for heterogeneously expressed genes in mouse ES cells. Gene Expr Patterns 2008; 8:18198.

33.

Silva J, Nichols J, Theunissen TW et al. Nanog is the gateway to the pluripotent ground state. Cell 2009; 138:72237.

34.

Jiang J, Chan YS, Loh YH et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 2008; 10:35360.

35.

Hall J, Guo G, Wray J et al. Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell 2009; 5:597609.

36.

Ema M, Mori D, Niwa H et al. Kruppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell 2008; 3:55567.

37.

Dejosez M, Krumenacker JS, Zitur LJ et al. Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell 2008; 133:116274.

38.

Hu G, Kim J, Xu Q et al. A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev 2009; 23:83748.

39.

Ding L, Paszkowski-Rogacz M, Nitzsche A et al. A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell 2009; 4:40315.

40.

Gaspar-Maia A, Alajem A, Polesso F et al. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 2009; 460:8638.

41.

Wang J, Rao S, Chu J et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006; 444:3648.

42.

Wu Q, Chen X, Zhang J et al. Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J Biol Chem 2006; 281:240904.

43.

Suzuki A, Raya A, Kawakami Y et al. Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells. Proc Natl Acad Sci USA 2006; 103:102949.

44.

Torres J, Watt FM. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3. Nat Cell Biol 2008; 10:194201.

45.

Araki R, Fukumura R, Sasaki N et al. More than 40,000 transcripts, including novel and noncoding transcripts, in mouse embryonic stem cells. Stem Cells 2006; 24:25228.

46.

Sharov AA, Piao Y, Matoba R et al. Transcriptome analysis of mouse stem cells and early embryos. PLoS Biol 2003; 1:E74.

47.

Nagalakshmi U, Wang Z, Waern K et al. The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 2008; 320:13449.

More here:
Transcriptional Regulation in Embryonic Stem Cells …

Global Cell Isolation Market Report Promising Growth of CAGR of 17.91% , Analysis of Top companies and their Share, Size,Scope and Current Trends -…

GlobalCell Isolation Marketreport would come in handy to understand your competitors and give you an insight into sales; volumes, revenues in the Cell Isolation industry, assists in making strategic decisions. Cell Isolation Market is expected to grow at a CAGR of 17.91% from 2020 to 2023 and explains why and how it is going to achieve this growth.It provides vital information on every parameter which is required for making strategic decisions and development of every business in the industry.

Request a Sample Copy of the Report For COVID-19 Impact Analysis onCell Isolation Market

About Cell Isolation Market The rise in demand for clinical diagnosis is one of the key factors anticipated to drive the cell isolation market growth during the forecast period. To effectively treat various diseases using genetic engineering tools, early diagnosis is essential. Genetic engineering tools provide diagnostic enzymes such as cholesterol oxidase and xylitol oxidase. These diagnostic enzymes identify specific cells like cells with high levels of cholesterol. When blood levels of these particular enzymes increase significantly, it indicates a probable site for tissue damage, which releases these enzymes in the blood. These enzymes are used in assays using samples of serum or urine. The isolation of these enzymes can provide the required enzymes for clinical diagnosis. Thus, genetic engineering tools are useful, precise, and economical for researchers and healthcare providers to diagnose patients. Research analysts have predicted that the cell isolation market will register a CAGR of almost 19% by 2023.

TheTop Manufacturers/playersincluding:-

Agilent Technologies Inc., Becton Dickinson and Co., Merck KGaA, QIAGEN NV, Thermo Fisher Scientific Inc.

Get a Sample PDF of report https://www.360marketupdates.com/enquiry/request-sample/14035352

Market Segment of Cell Isolation Industry:

Market Overview

Competitive Landscape

Feel Free to Ask Question Before Purchasing the Report at https://www.360marketupdates.com/enquiry/pre-order-enquiry/14035352

Cell Isolation Market Report provides comprehensive analysis of-

Key Summary of Cell Isolation Market Growth Report:

In our market size and forecast determination efforts, in-depth secondary research was initially completed to realize an honest perspective of the market in each region. Extensive primary research was also administered by interviewing key executives from the industry. These interviews helped us to fill-in the info gaps after secondary research. Several secondary sources like encyclopedia, directories, and databases are wont to identify and collect information useful for this extensive techno-commercial study.

Key Questions Answered in ROY Cell Isolation Market Report:

Purchase this report (Price2500 USD for a single-user license)@ https://www.360marketupdates.com/purchase/14035352

In the end, the Cell Isolation Market report makes some important proposals for a new project of the Cell Isolation Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of Global Cell Isolation Industry covering all important parameters.

Table of Contents included in Cell Isolation Market ROY Report

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by end-user industry

PART 07: Market segmentation by application

PART 08: Geographical Segmentation

PART 09: A Decision framework

PART 10: Impact of drivers and challengesAnd Many More Parts Covered.

Be sure to follow on Linkedin at @360 Market Updatesfor more on growth research and the research market.

CONTACT US

Name: Mr. Ajay More

Email: [emailprotected]

Organization: 360 Market Updates

Phone: +1 424 253 0807 / + 44 203 239 8187

OUR OTHER REPORTS:

TV Wall Market 2020 Recent Development and its impact on Market Share, Size, Sale, Growth Rate and Future Opportunity

Immunoassay Analyzers Market 2020 Recent Development and its impact on Market Share, Size, Sale, Growth Rate and Future Opportunity

Tetramethyl Orthosilicate (CAS 681-84-5) Market Report 2020 Indepth Analysis on Market Share, Size, Growth Rate and Factors, Future Developments and Prospects

Digital Education Projector Market 2020 Recent Development and its impact on Market Share, Size, Sale, Growth Rate and Future Opportunity

Aerospace Fabrics Market 2020 Global Industry Growth Rate, Share, Size, Price, Prospect, Developments and Forecast till 2025

More here:
Global Cell Isolation Market Report Promising Growth of CAGR of 17.91% , Analysis of Top companies and their Share, Size,Scope and Current Trends -…

Kerala’s KK Shailaja tops as women dominate top 10 of Prospect’s ‘thinkers for the COVID-19 age’ list – The New Indian Express

British monthly magazine ‘Prospect’ has announced that state Health Minister KK Shailaja has been selected as the world’s top thinker for the Covid-19 age.

The communist leader has been selected from a list of 50 personalities which include Jacinda Ardern, Prime Minister of New Zealand; philosopher Cornel West; historian of slavery Olivette Otele amongothers. (Photo | Prospect magazine)

#1 KK SHAILAJA (INDIAN POLITICIAN): ‘When Covid-19 was still a China story in January, she not only accurately foresaw its inevitable arrival, but also fully grasped the implications,’ the Magazine piece read. Other international media organisations like BBC, The New York Times, The Guardian and others in the past have also expressed appreciation for Kerala’s efforts in controling the spread of the pandemic. (Photo | Facebook/KK Shailaja Teacher)

#2 JACINDA ARDERN (NEW ZEALAND PRIME MINISTER): According to Prospect, Jacinda’s governing ethos of kindness was drawing interest as a refreshing (if hazy) alternative to neo-liberalism even before it showed practical results in keeping a lid on the crisis. (Photo | AP)

#3 MARINA TABASSUM (BANGLADESHI ARCHITECT): Marina Tabassum, is ‘another woman applying her mind to a pressing practical challenge, although in her case it is climate change: she designs houses on stilts to keep families safe from rising waters,’ states the magazine. (Photo | AFP)

#4 CORNEL WEST (US PHILOSOPHER): A veteran voice among African-American intellectuals, West have said that black liberation cannot happen without a wholesale rejection of capitalism. He is a prominent figure in the ‘Black Lives Matter’ movement. (Photo | AFP)

#5 ILONA SZABO DE CARVALHO (BRAZILIAN POLITICAL SCIENTIST): Ilona’s ‘Igarap Institute’ has been trying out ways to protect vulnerable citizens of Brazil against mafia activity and riots. Her team has been working to make the police force more accountable, prevent power abuse using digital technology and advocates the implementation of a ‘sensible drug policy.’ (Photo | Twitter)

#6 OLIOVETTE OETELE (UK’s FIRST FEMALE BLACK HISTORY PROF): An expert on the links between history, memory, and geopolitics in relation to French and British colonial pasts, Otele was born in Cameroon and grew up in Paris. The magazine identifies her as a keen analyst of Bristols impassioned debate over its long associations with slavery. (Photo | Twitter)

#7 RUTH WILSON GILMORE (US PRISON ABOLITIONIST): A seasoned campaigner against the prison-industrial complex, who now works in academia, hes helped shift the conversation about responses to crime from one of punishment to rehabilitation. As the failings of the US justice system come once again to the fore, Gilmores radical ideas have never felt more relevant,’ Prospect declared. (Photo | Facebook/National Women’s Studies Association)

#8 PHILIPPE VAN PARIJS (BELGIAN PHILOSOPHER): Considered the Goffather of Universal Basic Income (UBI) movement, Parijs advocates language tax which would be paid by English-speaking countries and ban on the dubbing of films, among other measures in order to address the ‘injustice’ arising from the ‘privilege’ enjoyed by English as a global language. (Photo | Facebook/Basic Income Earth Network)

#9 MARK POST (DUTCH PHARMACOLOGIST): Post identifies his goal as to replace the entirety of livestock production with cultured meat. His thought has attracted investment from Google co-founder Sergey Brin. His company ‘Mosa Meat’ targets to make commercially viable cultured meat available to the general public by 2021. (Photo | Mosa Meat website)

#10 MAGDALENA ZERNICKA-GOETZ (POLISH-BRITISH BIOLOGIST): Accroding to the magazine, ‘Her Cambridge team has shown how embryo-like structures can be made from scratch in the lab using embryonic stem cells (which can become any tissue) and other types of stem cell. Shes been able to grow human embryos in vitro right up to the current 14-day legal limit. Aside from its profound medical implications, her work raises philosophical questions about what it means to be human.’ (Photo | Caltech webiste)

Read more:
Kerala’s KK Shailaja tops as women dominate top 10 of Prospect’s ‘thinkers for the COVID-19 age’ list – The New Indian Express

Cell Therapy Manufacturing Market to be Worth USD 8 billion by 2030, predicts Roots Analysis – Scientect

Roots Analysis has announced the addition of Cell Therapy Manufacturing Market (2nd Edition), 2018-2030 report to its list of offerings.

Natasha Thakur, the principal analyst, stated, The growing number of cell therapy candidates continues to create an increasing demand for facilities that offer manufacturing services for these complex pharmacological interventions. Presently, over 145 companies / organizations are actively offering manufacturing services for such products. The installed global manufacturing capacity is estimated to be over 1 billion sq ft, with the maximum capacity available in North America

The report presents opinions on several key aspects of the market. Among other elements, it includes:

The report features inputs from a number of eminent industry stakeholders. Thakur remarked, Most of the experts we spoke to confirmed that the manufacturing of cell therapies is largely being outsourced due to exorbitant costs associated with setting-up such facilities. The report features detailed transcripts of discussions held with the following experts:

The research also includes detailed profiles of the following players:

For additional details, please visithttps://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing-market-2nd-edition-2018-2030/209.hl or email [emailprotected]

Contact:

Gaurav Chaudhary

+1-604-595-4954

Continued here:
Cell Therapy Manufacturing Market to be Worth USD 8 billion by 2030, predicts Roots Analysis – Scientect

Market Growth of Global Stem Cells to Remain Sluggish through 2020 2030 – The News Brok

The success of approved stem cell therapies has caused a surge in interest of biopharma developers in this field; many innovator companies are currently progressing proprietary leads across different phases of clinical development, with cautious optimism

Roots Analysis has announced the addition of Global Stem Cells Market: Focus on Clinical Therapies, 20202030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent)) report to its list of offerings.

There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years.

To order this 500+ page report, which features 185+ figures and 220+ tables, please visit this link

Over 280 stem cell therapies are under development, most of which are allogeneic products More than 50% of the pipeline candidates are in the mid to late phase trials (phase II and above), and allogenic therapies (majority of which are derived from the bone marrow) make up 65% of the pipeline.

70% of pipeline candidates are based on mesenchymal stem cells It is worth highlighting that the abovementioned therapies are designed to treat musculoskeletal (22%), neurological (21%) and cardiovascular (15%) disorders. On the other hand, hematopoietic stem cell-based products are mostly being evaluated for the treatment of oncological disorders, primarily hematological malignancies.

Close to 85% stem cell therapy developers are based in North America and Asia-Pacific regions Within these regions, the US, China, South Korea and Japan, have emerged as key R&D hubs for stem cell therapies. It is worth noting that majority of the initiatives in this domain are driven by small / mid-sized companies

Over 1,500 grants were awarded for stem cell research, since 2015 More than 45% of the total amount was awarded under the R01 mechanism (which supports research projects). The NCI, NHLBI, NICHD, NIDDK, NIGMS and OD emerged as key organizations that have offered financial support for time periods exceeding 25 years as well.

Outsourcing has become indispensable to R&D and manufacturing activity in this domain Presently, more than 80 industry / non-industry players, based in different regions across the globe, claim to provide contract development and manufacturing services to cater to the unmet needs of therapy developers. Examples include (in alphabetical order) Bio Elpida, Cell and Gene Therapy Catapult, Cell Tech Pharmed, GenCure, KBI Biopharma, Lonza, MEDINET, Nikon CeLL innovation, Roslin Cell Therapies, WuXi Advanced Therapies and YposKesi.

North America and Asia-Pacific markets are anticipated to capture over 80% share by 2030 The stem cell therapies market is anticipated to witness an annualized growth rate of over 30% during the next decade. Interestingly, the market in China / broader Asia-Pacific region is anticipated to grow at a relatively faster rate.

To request a sample copy / brochure of this report, please visit this link

The USD 8.5 billion (by 2030) financial opportunity within the stem cell therapies market has been analyzed across the following segments:

The report features inputs from eminent industry stakeholders, according to whom stem cell therapies are currently considered to be a promising alternatives for the treatment of a myriad of disease indications, with the potential to overcome challenges associated with conventional treatment options. The report includes detailed transcripts of discussions held with the following experts:

The research covers brief profiles of several companies (including those listed below); each profile features an overview of the company, financial information (if available), stem cell therapy portfolio and an informed future outlook.

For additional details, please visit https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html

or email [emailprotected]

You may also be interested in the following titles:

Contact:

Gaurav Chaudhary +1 (415) 800 3415 +44 (122) 391 1091 [emailprotected]

Continue reading here:
Market Growth of Global Stem Cells to Remain Sluggish through 2020 2030 – The News Brok